Clinical Trials for Aptabio Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aptabio Therapeutics

Clinical Trials (3)

NCT07123415
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
PHASE1Not yet recruiting
110 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor0 locations
NCT06962098
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
PHASE2Recruiting
186 participants
Started: May 26, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor20 locations
NCT05758896
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
PHASE2Recruiting
280 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor14 locations